Page 3 - Vivos Method News Today

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Earnings and Valuation This table compares Vivos […]

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) saw a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 1,140,000 shares, a growth of 1,388.3% from the July 31st total of 76,600 shares. Based on an average trading volume of 1,540,000 shares, the short-interest ratio […]

Vivos says it was negatively impacted in Q2 by governmental investigations into third parties offering non-FDA-approved oral appliances.

Call Scheduled for Monday, August 14, 2023 at 5:00 pm ET...

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 70,600 shares, a drop of 69.7% from the June 15th total of 232,900 shares. Based on an average daily volume of 156,500 shares, […]

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Westaim (OTCMKTS:WEDXF – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Valuation and Earnings This table compares Vivos Therapeutics and Westaim’s […]

Westaim (OTCMKTS:WEDXF – Get Rating) and Vivos Therapeutics (NASDAQ:VVOS – Get Rating) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Profitability This table compares Westaim and Vivos Therapeutics’ net […]

Vivos, a maker of oral appliances for treating breathing-related sleep disorders, implemented initiatives to improve operational efficiencies.

LITTLETON, Colo., May 01, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic

Vivos Therapeutics (NASDAQ:VVOS), Inc has announced its fiscal 2022 financial results and provided an operational update, saying it believes its 2022 and...